Saturday Night Quarterback says (on a Sunday), For the week ahead expect…
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Trick or Trend: Strong dollar big trend in earnings reports for drugs, consumer, and capital equipment stocks
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Notes You Need for January 11 (Updated 4:20 p.m.): Drug stocks, oil inventories, Brazil interest rates, oil refineries, PC sales
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Incyte ended the year with news; begins 2017 the same way–and climbs 9.44% on the day
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Acadia Pharmaceutical shares pop 11% on buyout rumors
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...Notes You Need for December 14: Drug R&D, GOOG,AMZN
To subscribe to JAM you need to fill in some details below including, ahem, some info on how you'll pay us. A subscription is $199 (although if you're subscribing with one of our special offers it will be lower) for a year for ongoing and continuing access to the...So much for the Trump victory drug rally
“I’m going to bring down drug prices. I don’t like what’s happened with drug prices,” President-elect Donald Trump said in an interview with Time posted on the magazine’s website this morning. So much, the stock market has concluded today, for the idea that a President Trump would be friendlier than a President Clinton to the drug industry.
